Kelly Financial Services LLC Ionis Pharmaceuticals Inc Transaction History

Kelly Financial Services LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Jul 17, 2024	SELL	$33.54 - $40.55 $39,141 - $47,321	-1,167 Reduced 97.49%	30 $1.01 Million
Q2 2021 Jul 17, 2024	BUY	$34.54 - $47.25 $19,584 - $26,790	567 Added 90.0%	1,197 $30,000
Q1 2021 Jul 17, 2024	SELL	$42.51 - $63.78 $14,368 - $21,557	-338 Reduced 34.92%	630 $28.3 Million
Q3 2019 Jul 17, 2024	SELL	$59.06 - $72.15 $1,889 - $2,308	-32 Reduced 3.2%	968 $58 Million
Q1 2019 Jul 17, 2024	BUY	$52.92 - $81.17 $52,920 - $81,170	1,000 New	1,000 $81.2 Million

388

125M

2.19M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.56B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Kelly Financial Services LLC with notifications on news.